Bracco S.p.A.

About Bracco S.p.A.

Bracco S.p.A. is an Italian multinational corporation specializing in diagnostic imaging and pharmaceuticals. Founded in 1927, the company develops, manufactures, and markets contrast agents for magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, and nuclear medicine, as well as related drug delivery systems and radiopharmaceuticals. Bracco also operates in the healthcare technology sector, offering advanced imaging solutions, software, and services that enhance diagnostic accuracy and patient care. With a strong focus on research and innovation, Bracco maintains a global presence across Europe, North America, and Asia, serving hospitals, clinics, and research institutions while adhering to stringent quality and regulatory standards.